» Articles » PMID: 24391602

Mismatch Negativity: Translating the Potential

Overview
Specialty Psychiatry
Date 2014 Jan 7
PMID 24391602
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

The mismatch negativity (MMN) component of the auditory event-related potential has become a valuable tool in cognitive neuroscience. Its reduced size in persons with schizophrenia is of unknown origin but theories proposed include links to problems in experience-dependent plasticity reliant on N-methyl-d-aspartate glutamate receptors. In this review we address the utility of this tool in revealing the nature and time course of problems in perceptual inference in this illness together with its potential for use in translational research testing animal models of schizophrenia-related phenotypes. Specifically, we review the reasons for interest in MMN in schizophrenia, issues pertaining to the measurement of MMN, its use as a vulnerability index for the development of schizophrenia, the pharmacological sensitivity of MMN and the progress in developing animal models of MMN. Within this process we highlight the challenges posed by knowledge gaps pertaining to the tool and the pharmacology of the underlying system.

Citing Articles

Predicting the unpredicted … brain response: A systematic review of the feature-related visual mismatch negativity (vMMN) and the experimental parameters that affect it.

Male A PLoS One. 2025; 20(2):e0314415.

PMID: 40014603 PMC: 11867396. DOI: 10.1371/journal.pone.0314415.


Effect of antipsychotic on mismatch negativity amplitude and evoked theta power in drug-naïve patients with schizophrenia.

Xiong Y, Bo Q, Li X, Liu Y, Guo Q, Wang C BMC Psychiatry. 2024; 24(1):901.

PMID: 39696022 PMC: 11653912. DOI: 10.1186/s12888-024-06314-w.


Opportunities for use of neuroimaging in de-risking drug development and improving clinical outcomes in psychiatry: an industry perspective.

Etkin A, Powell J, Savitz A Neuropsychopharmacology. 2024; 50(1):258-268.

PMID: 39169213 PMC: 11526012. DOI: 10.1038/s41386-024-01970-8.


EVIDENCE FOR AUDITORY STIMULUS-SPECIFIC ADAPTATION BUT NOT DEVIANCE DETECTION IN LARVAL ZEBRAFISH BRAINS.

Wilde M, Poulsen R, Qin W, Arnold J, Favre-Bulle I, Mattingley J bioRxiv. 2024; .

PMID: 38915708 PMC: 11195219. DOI: 10.1101/2024.06.14.597058.


Why mismatch negativity continues to hold potential in probing altered brain function in schizophrenia.

Todd J, Salisbury D, Michie P PCN Rep. 2024; 2(3):e144.

PMID: 38867817 PMC: 11114358. DOI: 10.1002/pcn5.144.


References
1.
Hermens D, Ward P, Hodge M, Kaur M, Naismith S, Hickie I . Impaired MMN/P3a complex in first-episode psychosis: cognitive and psychosocial associations. Prog Neuropsychopharmacol Biol Psychiatry. 2010; 34(6):822-9. DOI: 10.1016/j.pnpbp.2010.03.019. View

2.
Tikhonravov D, Neuvonen T, Pertovaara A, Savioja K, Ruusuvirta T, Naatanen R . Dose-related effects of memantine on a mismatch negativity-like response in anesthetized rats. Neuroscience. 2010; 167(4):1175-82. DOI: 10.1016/j.neuroscience.2010.03.014. View

3.
Pantelis C, Velakoulis D, Wood S, Yucel M, Yung A, Phillips L . Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. Int Rev Psychiatry. 2007; 19(4):371-81. DOI: 10.1080/09540260701512079. View

4.
Murray R, Lappin J, Di Forti M . Schizophrenia: from developmental deviance to dopamine dysregulation. Eur Neuropsychopharmacol. 2008; 18 Suppl 3:S129-34. DOI: 10.1016/j.euroneuro.2008.04.002. View

5.
Dunbar G, Boeijinga P, Demazieres A, Cisterni C, Kuchibhatla R, Wesnes K . Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers. Psychopharmacology (Berl). 2007; 191(4):919-29. DOI: 10.1007/s00213-006-0675-x. View